These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32604538)

  • 1. pH-Sensitive Drug Delivery System Based on Mesoporous Silica Modified with Poly-L-Lysine (PLL) as a Gatekeeper.
    Lee NK; Park SS; Ha CS
    J Nanosci Nanotechnol; 2020 Nov; 20(11):6925-6934. PubMed ID: 32604538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Adjustable pH-Responsive Drug Delivery System Based on Self-Assembly Polypeptide-Modified Mesoporous Silica.
    Yang C; Shi Z; Feng C; Li R; Luo S; Li X; Ruan L
    Macromol Biosci; 2020 Jun; 20(6):e2000034. PubMed ID: 32329202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release.
    Li QL; Sun Y; Sun YL; Wen J; Zhou Y; Bing QM; Isaacs LD; Jin Y; Gao H; Yang YW
    Chem Mater; 2014 Nov; 26(22):6418-6431. PubMed ID: 25620848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticles for drug and gene delivery.
    Zhou Y; Quan G; Wu Q; Zhang X; Niu B; Wu B; Huang Y; Pan X; Wu C
    Acta Pharm Sin B; 2018 Mar; 8(2):165-177. PubMed ID: 29719777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
    Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
    Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Polyzwitterion and Polydopamine Decorated Doxorubicin-Loaded Mesoporous Silica Nanoparticles as a pH-Sensitive Drug Delivery.
    Ji F; Sun H; Qin Z; Zhang E; Cui J; Wang J; Li S; Yao F
    Polymers (Basel); 2018 Mar; 10(3):. PubMed ID: 30966361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
    Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
    Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.
    Bhavsar DB; Patel V; Sawant KK
    Eur J Pharm Sci; 2020 Sep; 152():105428. PubMed ID: 32553643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-stimuli responsive hollow MnO
    Xu X; Duan J; Liu Y; Kuang Y; Duan J; Liao T; Xu Z; Jiang B; Li C
    Acta Biomater; 2021 May; 126():445-462. PubMed ID: 33785453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Three-in-One" Multifunctional Gatekeeper Gated Mesoporous Silica Nanoparticles for Intracellular pH-Activated Targeted Cancer Therapy.
    Zhang Y; Wang W; Zhang Y; Cheng M; Wu Q; Yuan Z
    ACS Appl Bio Mater; 2018 Sep; 1(3):572-580. PubMed ID: 34996191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded electrospun poly(l-lactic acid)/mesoporous silica nanoparticles composite nanofibers for potential postsurgical cancer treatment.
    Qiu K; He C; Feng W; Wang W; Zhou X; Yin Z; Chen L; Wang H; Mo X
    J Mater Chem B; 2013 Sep; 1(36):4601-4611. PubMed ID: 32261203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ingenious pH-sensitive dextran/mesoporous silica nanoparticles based drug delivery systems for controlled intracellular drug release.
    Zhang M; Liu J; Kuang Y; Li Q; Zheng DW; Song Q; Chen H; Chen X; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2017 May; 98():691-700. PubMed ID: 28174081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
    Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
    Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
    Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.